0 01/04/2024 31/03/2025 2025-03-31 false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2024-04-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 09129717 2024-04-01 2025-03-31 09129717 2025-03-31 09129717 2024-03-31 09129717 2023-04-01 2024-03-31 09129717 2024-03-31 09129717 2023-03-31 09129717 bus:RegisteredOffice 2024-04-01 2025-03-31 09129717 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 09129717 bus:Director1 2024-04-01 2025-03-31 09129717 bus:Director2 2024-04-01 2025-03-31 09129717 core:WithinOneYear 2025-03-31 09129717 core:WithinOneYear 2024-03-31 09129717 core:AfterOneYear 2025-03-31 09129717 core:AfterOneYear 2024-03-31 09129717 bus:Director1 2024-03-31 09129717 bus:Director1 2025-03-31 09129717 bus:Director1 2023-03-31 09129717 bus:Director1 2024-03-31 09129717 bus:Director1 2023-04-01 2024-03-31 09129717 bus:Micro-entities 2024-04-01 2025-03-31 09129717 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09129717 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 09129717 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09129717 bus:FullAccounts 2024-04-01 2025-03-31
Company registration number: 09129717
Pharmapal (UK) Limited
Unaudited filleted financial statements
31 March 2025
Pharmapal (UK) Limited
Contents
Directors and other information
Statement of financial position and notes to the financial statements
Pharmapal (UK) Limited
Directors and other information
Directors Mr R K Palamoudian
Mr B Palamoudian
Company number 09129717
Registered office 404 Centennial Avenue
Elstree
Borehamwood WD6 3TN
Accountants Michael Leong and Company
43 Overstone Road
London W6 0AD
Bankers Barclays Bank Plc
197 Shenley Road
Borehamwood
Herts WD6 1AR
Pharmapal (UK) Limited
Statement of financial position
31 March 2025
2025 2024
£ £ £ £
Fixed assets 557,469 571,763
_______ _______
Current assets 2,837 899
Prepayments and accrued income 1,001 1,373
_______ _______
3,838 2,272
Creditors: amounts falling due within one year ( 22,633) ( 21,524)
_______ _______
Net current liabilities ( 18,795) ( 19,252)
_______ _______
Total assets less current liabilities 538,674 552,511
Creditors: amounts falling due after more than one year ( 395,064) ( 432,564)
Accruals and deferred income ( 1,600) ( 1,500)
_______ _______
Net assets 142,010 118,447
_______ _______
Capital and reserves 142,010 118,447
_______ _______
Notes to the financial statements
Pharmapal (UK) Limited
Year ended 31 March 2025
1. Directors advances, credits and guarantees
During the year the directors entered into the following advances and credits with the company:
2025
Balance brought forward Amounts repaid Balance o/standing
£ £ £
Mr R K Palamoudian ( 432,564) 37,500 ( 395,064)
_______ _______ _______
2024
Balance brought forward Amounts repaid Balance o/standing
£ £ £
Mr R K Palamoudian ( 471,064) 38,500 ( 432,564)
_______ _______ _______
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 17 June 2025 , and are signed on behalf of the board by:
Mr R K Palamoudian
Director
Company registration number: 09129717
The company is a private company limited by shares, registered in England and Wales.